Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $16.1 Million - $21 Million
85,700 New
85,700 $16.9 Million
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $10 Million - $14.2 Million
-39,200 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $13.8 Million - $17.6 Million
39,200 New
39,200 $14.8 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Oribel Capital Management, LP Portfolio

Follow Oribel Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oribel Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Oribel Capital Management, LP with notifications on news.